Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Steam treatment eases prostate symptoms without major surgery

NCT ID NCT07507591

Symptom relief Sponsor: ALI KAMAL M. SAMI Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a treatment called Rezūm, which uses water vapor (steam) to shrink an enlarged prostate. It included 129 men aged 45 to 96 who had trouble urinating. The goal was to see if the treatment is safe and works well when done under local anesthesia with sedation. Results showed improved urinary symptoms and quality of life with few serious side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

129 people

The number who actually took part.

Started

Sep 2025

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Male patients with moderate-to-severe lower urinary tract symptoms secondary to benign prostatic hyperplasia who underwent Rezūm water vapor thermal therapy at Royal Hospital, Sulaymaniyah, Kurdistan Region of Iraq.

Ages

45 to 96 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Male patients aged 45 years or older. 2. Moderate-to-severe lower urinary tract symptoms secondary to benign prostatic hyperplasia (IPSS ≥8). 3. Maximum urinary flow rate (Qmax) less than 15 mL/s on uroflowmetry. 4. Prostate volume 30 to 120 g on transrectal or transabdominal ultrasonography. 5. Failure of medical therapy or intolerance to medical therapy. 6. Catheter-dependent urinary retention secondary to benign prostatic hyperplasia in patients who were not candidates for or declined conventional surgical intervention. 7. Consecutive patients who underwent Rezūm water vapor thermal therapy during the study period. Exclusion Criteria: 1. Pre-existing erectile dysfunction not attributable to benign prostatic hyperplasia medication side effects. 2. Retrograde ejaculation not caused by alpha-blocker therapy. 3. Lower urinary tract symptoms attributable to causes other than benign prostatic hyperplasia, including neurogenic bladder or bladder overactivity unrelated to benign prostatic hyperplasia. 4. History of previous bladder surgery, prostate surgery, or urethral stricture surgery. 5. Presence of vesical calculi. 6. Confirmed neurogenic bladder. 7. Suspected or confirmed prostate malignancy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Benign prostate hyperplasia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia Lower Urinary Tract Symptoms Urinary Retention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Benign prostate hyperplasia

Contacts and locations

Locations

  • Royal Hospital

    Sulaymaniyah, Kurdistan Region of Iraq (kri), 46001, Iraq

More trials for these conditions

Other studies related to the condition(s) this trial covers.